DGX logo

Quest Diagnostics Stock Price

Symbol: NYSE:DGXMarket Cap: US$19.5bCategory: Healthcare

DGX Share Price Performance

US$176.96
27.65 (18.52%)
6.0% undervalued intrinsic discount
US$188.19
Fair Value
US$176.96
27.65 (18.52%)
6.0% undervalued intrinsic discount
US$188.19
Fair Value
Price US$176.96
AnalystConsensusTarget US$188.19

DGX Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value US$188.19 6.0% undervalued intrinsic discount

Preventive Diagnostics And Automation Will Shape Future Healthcare

0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative

Recent DGX News & Updates

No updates

Quest Diagnostics Incorporated Key Details

US$10.5b

Revenue

US$7.0b

Cost of Revenue

US$3.5b

Gross Profit

US$2.6b

Other Expenses

US$945.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
8.45
Gross Margin
33.26%
Net Profit Margin
8.98%
Debt/Equity Ratio
77.2%

Quest Diagnostics Incorporated Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About DGX

Founded
1967
Employees
50500
CEO
James Davis
WebsiteView website
www.questdiagnostics.com

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

U.S. Market Performance

  • 7 Days: 2.3%
  • 3 Months: 12.9%
  • 1 Year: 20.2%
  • Year to Date: 8.3%
The market is up 2.3% over the last week, with the Information Technology sector leading the way, up 4.1%. The market is up 20% over the last 12 months. Earnings are forecast to grow by 15% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading